Mark Fishman

Mark Fishman is an American cardiologist. A researcher and clinician in cardiology, he is the previous president of the Novartis Institutes for BioMedical Research (NIBR),[1] the main research arm of Novartis Pharmaceuticals.[2]

Mark Fishman
Alma materYale College, Harvard Medical School
Known forpioneering Zebrafish research in cardiology
AwardsInstitute of Medicine member, Fellow of the American Academy of Arts and Sciences
Scientific career
FieldsMedicine, Cardiology
InstitutionsNovartis Institutes of BioMedical Research, Massachusetts General Hospital, Harvard Medical School

Fishman was appointed president of the newly founded Novartis Institutes for BioMedical Research in 2002 to implement a new strategy in Novartis' global drug discovery effort.[3] He is the author of over 100 publications[4] and known for pioneering research using the zebrafish as a means of visualizing the development of the circulatory system and as a model for human disease.[5][6][7]

Education

Career

He was previously a professor of medicine at Harvard Medical School, chief of cardiology at Massachusetts General Hospital, and director of the Cardiovascular Research Center at Massachusetts General Hospital. He is a fellow of the National Academy of Arts and Sciences and a member of the National Academy of Sciences, Institute of Medicine.[8]

After being the head of Novartis for 13 years, he decided to retire in 2016.[9]

References
  1. "Archived copy". Archived from the original on 2015-06-01. Retrieved 2009-10-20.{{cite web}}: CS1 maint: archived copy as title (link)
  2. "Archived copy". Archived from the original on 2011-02-02. Retrieved 2009-10-20.{{cite web}}: CS1 maint: archived copy as title (link)
  3. "Archived copy". Archived from the original on 2011-06-16. Retrieved 2009-10-20.{{cite web}}: CS1 maint: archived copy as title (link)
  4. http://www.pubmed.gov 183 results as of 20 Oct 2009
  5. Barut, Bruce A.; Zon, Leonard I. (2000). "Realizing the potential of zebrafish as a model for human disease". Physiological Genomics. 2 (2): 49–51. doi:10.1152/physiolgenomics.2000.2.2.49. PMID 11015581. S2CID 12510521.
  6. Forbes.com
  7. "Archived copy" (PDF). Archived from the original (PDF) on 2011-07-25. Retrieved 2009-10-20.{{cite web}}: CS1 maint: archived copy as title (link)
  8. "Media" (PDF).
  9. "Fierce Biotech". 24 September 2015. Retrieved 13 December 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.